[April 23, 2014]

Strides in Preventive Healthcare Create Investment Opportunities, says Reynders, McVeigh Capital Management

Reynders, McVeigh Capital Management today issued a new insight paper, "Preventive Healthcare: Disruption in a Shifting Sector." The paper notes that a nationwide emphasis on lower cost healthcare solutions is opening doors for new leaders and investment opportunities.

Co-authored by Chat Reynders, CEO and Chairman of Reynders, McVeigh, and Patrick McVeigh, President and Chief Investment Officer, the paper highlights three shifting elements of healthcare:

• Generics supplanting brand name drugs:
  Generic drugs areplaying a major role in driving down medication costs, and are generating high margin opportunities for well-positioned retail pharmacies. A similar theme is likely to unfold as biosimilars come to market, although regulatory hurdles remain in the U.S.

• Preventive clinical care is entering the mainstream:
  
  
  
  
  The most dramatic shift in everyday care can be seen in the emergence of the walk-in clinic model among pharmacies. Major retailers are contributing to the diagnosis and treatment of minor ailments, mitigating the burden on primary care physicians and emergency rooms.

• Technology is enabling improved self-care:
  Technology is allowing advancements in monitoring and containing conditions, which help to reduce flare-ups and hospital visits. Wearable units for diabetes patients are particularly noteworthy, as companies compete to introduce new solutions to routine insulin monitoring and injections.

"We're excited about companies that are poised to capitalize on healthcare disruption and a new frontier of medicine," write Reynders and McVeigh. "As investors, we see an enormous opportunity regarding the improvements in preventive care and its role in evolving global health culture."

For more detail, please download "Preventive Healthcare: Disruption in a Shifting Sector" on Reynders McVeigh's Insights page at http://reyndersmcveigh.com/insights.php.

About Reynders, McVeigh Capital Management:

Reynders, McVeigh Capital Management is a Boston-based investment management firm focused on socially progressive investments, creating portfolios with cores comprised of companies that emphasize social impact. The firm has approximately $1 billion in assets under management and advises on an additional $5 billion for trust offices around the country. Listed consistently in the top 100 in AdvisorOne's annual Top Wealth Managers Rankings, Reynders, McVeigh leverages its proprietary research and emphasizes transparency, discretion, and a due diligence process in support of each investment to construct individually tailored portfolios for high net worth clients.

For more information, please visit www.reyndersmcveigh.com.

[ Back To TMCnet.com's Homepage ]